Diseases beware! Researchers make crucial breakthrough in cell research
This method could have the potential for the next stage of drug delivery
It is a breakthrough in cell research that's poised to open up new possibilities in the fight against diseases. In cooperation with researchers from the China University of Petroleum, the working group of Dr. Werner Nau, Professor of Chemistry at Constructor University, has demonstrated the effectiveness of a new method of intracellular protein transport. The results of their research can now be read in Proceedings of the National Academy of Sciences (PNAS).
The finding's inclusion in the multidisciplinary publication released by the National Academy of Sciences of the United States of America underscores the significance of the group's discovery. “We are the first to succeed in transporting a completely functional protein into living cells without disrupting cellular integrity – simply by adding a small molecule,” says Nau. This method could have the potential for the next stage of drug delivery.
Cells are masters of self-defense, they protect themselves with a multitude of barriers. Circumventing them to deliver a therapeutic protein into a cell undamaged is a central goal of research. While previous methods have mainly relied on the encapsulation of proteins, researchers at Constructor University, on the other hand, utilized boron cluster anions as a molecular transport vehicle, which they use to place a protein called cytochrome C in the cells. Here it can unfold its toxic activity and eventually induce cell death.
Boron clusters are an inorganic, water-soluble compound that are not degraded by enzymes or bacteria in the body. “They are a highly efficient means of protein transport,” says Dr. Andrea Barba-Bon, a young scientist in Nau's research group. The protein remains bioactive in the cell and can carry out its task, such as fighting tumors.
“Intracellular delivery of proteins has the potential to revolutionize cell biology research and medical therapy, with broad applications in bioimaging, disease treatment and genome editing,” the study states. The next step in research is now to make protein transport more targeted in order to combat individual diseases more directly. “But this is a long process,” says Andrea Barba-Bon.
Original publication
Xiqi Ma, Zhixiong Zhang, Andrea Barba-Bon, Dongxue Han, Zichun Qi, Baosheng Ge, Hua He, Fang Huang, Werner M. Nau, Xiaojuan Wang; "A small-molecule carrier for the intracellular delivery of a membrane-impermeable protein with retained bioactivity"; Proceedings of the National Academy of Sciences, Volume 121, 2024-10-22
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
